Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 215,456 | 88,559 | 92,154 | 657,453 | 621,379 |
| Receivables | 46,745 | 81,886 | 129,122 | 115,458 | 114,042 |
| Other current assets | 0 | 0 | 0 | 0 | 1,115 |
| TOTAL | $274,178 | $182,368 | $233,288 | $780,626 | $745,225 |
| Non-Current Assets | |||||
| PPE Net | 3,408 | 4,495 | 5,585 | 6,288 | 7,575 |
| Intangibles | 2,040 | 2,860 | 3,682 | 0 | 0 |
| Other Non-Current Assets | 117,275 | 161,185 | 228,518 | 313,605 | 374,127 |
| TOTAL | $122,723 | $168,540 | $237,785 | $319,893 | $381,702 |
| Total Assets | $396,901 | $350,908 | $471,073 | $1,100,519 | $1,126,927 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 199,680 | N/A | 199,560 | N/A | 116,858 |
| Accounts payable and accrued liabilities | 2,898 | 2,127 | 7,830 | 483 | 935 |
| Accrued Expenses | 36,388 | 33,530 | 65,585 | 21,958 | 39,462 |
| Other current liabilities | N/A | N/A | N/A | 19 | 1,316 |
| TOTAL | $242,218 | $38,846 | $276,101 | $25,525 | $161,698 |
| Non-Current Liabilities | |||||
| Long Term Debt | 385,000 | 385,000 | 300,000 | N/A | N/A |
| Other Non-Current Liabilities | 31,518 | 228,397 | 270,587 | 422,616 | 359,318 |
| TOTAL | $416,518 | $613,397 | $541,267 | $422,616 | $359,318 |
| Total Liabilities | $658,736 | $652,243 | $817,368 | $448,141 | $521,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163,058 | 161,809 | 156,529 | 154,158 | 159,222 |
| Common Shares | 163 | 160 | 156 | 154 | 162 |
| Retained earnings | -1,673,718 | -1,697,735 | -1,698,615 | -696,376 | -937,608 |
| Other shareholders' equity | -1,060 | 923 | -3,031 | 0 | 0 |
| TOTAL | $-261,835 | $-301,335 | $-346,295 | $652,378 | $605,911 |
| Total Liabilities And Equity | $396,901 | $350,908 | $471,073 | $1,100,519 | $1,126,927 |